Year: 2022

news_6

Overland Pharmaceuticals Appoints Ed Zhang as Chief Executive Officer and Welcomes Industry Leaders John Maraganore and Peter Ho as Strategic Advisors

SHANGHAI & BOSTON--(BUSINESS WIRE)--Overland Pharmaceuticals (“Overland”), a premier biopharmaceutical company bringing innovative medicines to patients in Asia and worldwide, today...

news_6

Kurita Accelerates Overseas Promotion of Functional Materials for High Purity Ultrapure Water Production to Help Advance Production Technologies in Semiconductor Industry

TOKYO--(BUSINESS WIRE)--Kurita Water Industries Ltd. (TOKYO: 6370) (Head Office: Nakano-ku, Tokyo; President: Michiya Kadota; hereinafter "Kurita") is pleased to announce...

news_6

AffaMed Therapeutics, licensee of DEXTENZA® in Certain Asian Markets, Doses Their First Patient in Clinical Trial Evaluating the Safety and Efficacy of DEXTENZA® in China in Cataract Surgery Patients

BEDFORD, Mass.--(BUSINESS WIRE)--$OCUL #OCUTX--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies...